About
GeneFo provides a real-time crowdsourcing platform that classifies and matches patients who have the same condition according to the genetic alteration related to their specific condition. The platform enables patients to receive peer advice, medical feedback from in-house health professionals, personal condition progress reports, and clinical trial matching. Researchers can also use the platform to analyze patient-driven data from a phenotypic prism. GeneFo captures patient data in clear clinical categories and delivers the information in a single screen that organizes data through a smart newsfeed, helping users find the medical information they need in seconds.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the operational status of GeneFo?
- GeneFo is currently inactive and ceased operations in June 2019.
- What is GeneFo's primary business activity?
- GeneFo provides a real-time crowdsourcing platform that classifies and matches patients with the same condition based on genetic alterations, offering peer advice, medical feedback, progress reports, and clinical trial matching.
- When was GeneFo founded?
- GeneFo was founded in September 2014.
- What was a key offering from GeneFo in March 2018 related to Cystic Fibrosis?
- In March 2018, GeneFo released an updated guide to help Cystic Fibrosis patients with treatment options.
- What type of guide did GeneFo offer to Fibromyalgia patients in March 2018?
- In March 2018, GeneFo offered Fibromyalgia patients a free guide to applying for medical cannabis.
- What support did GeneFo provide to Parkinson's patients in March 2018?
- In March 2018, GeneFo provided a medical cannabis guide to help Parkinson's patients with their applications.
- What type of event did GeneFo promote for Cystic Fibrosis patients in September 2017?
- In September 2017, GeneFo promoted a free online webinar on humor and laughter as therapy for Cystic Fibrosis.
- With which company did GeneFo partner for a webinar on mitochondrial antioxidants and MS in August 2017?
- In August 2017, GeneFo partnered with MitoQ to hold a webinar on the link between mitochondrial antioxidants and Multiple Sclerosis.
- What did GeneFo offer to Multiple Sclerosis patients in June 2016 in collaboration with MitoQ?
- In June 2016, GeneFo and MitoQ offered an antioxidant supplement at a discount to Multiple Sclerosis patients.
- What research did GeneFo conduct in April 2016?
- In April 2016, GeneFo conducted a survey of Cystic Fibrosis patients.